BusinessAdmera Health Launches New Tests for Cancer Supportive Care and Liquid Biopsy, Now Provides a Comprehensive Portfolio of Oncology ProductsBy Nasdaq OMXOct 31, 2017, 1:13 PM UTC
BusinessAdmera Health Expands Asian Footprint with Three Strategic PartnershipsBy Nasdaq OMXSep 12, 2017, 3:05 PM UTC
BusinessNew York Medical College and Touro College of Pharmacy Team to Offer Pharmacogenomics CME Course Sponsored by Admera HealthBy Nasdaq OMXAug 8, 2017, 1:59 PM UTC
BusinessColumbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric MedicationsBy Nasdaq OMXJul 25, 2017, 11:00 PM UTC
BusinessInternationally Recognized Pharmacogenomic Expert Dr. Howard McLeod Joins Admera Health’s Advisory BoardBy Nasdaq OMXMay 17, 2017, 1:13 PM UTC
BusinessUniversity of Rochester School of Medicine and Dentistry Collaborate with Admera Health in a Clinical Study, Evaluating Pharmacogenomics in Acute Surgical Pain ManagementBy Nasdaq OMXMay 9, 2017, 1:13 PM UTC
BusinessHealth in Code’s Novel Work Published In JACC, Helps Increase Sensitivity Detection for Admera Health’s CardioGxOne™ Test Regarding Patients with High-Risk Dilated and Arrhythmogenic CardiomyopathiesBy Nasdaq OMXMay 3, 2017, 1:13 PM UTC
BusinessAdmera Health Reaches Significant Major Milestone in Achieving New York Department of CLEP Approval for PGxOne™ Plus, a 25 Gene Pharmacogenomics TestBy Nasdaq OMXNov 1, 2016, 1:13 PM UTC
